KPTI
Karyopharm Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$215.30M
P/E Ratio
—
EPS
$-16.40
Beta
0.82
52W High
$10.99
52W Low
$3.65
50-Day MA
$8.55
200-Day MA
$7.24
Dividend Yield
—
Profit Margin
-129.00%
Forward P/E
—
PEG Ratio
-0.15
About Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery, development and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is headquartered in Newton, Massachusetts.
Fundamentals
| Revenue (TTM) | $151.12M |
| Gross Profit (TTM) | $20.33M |
| EBITDA | $-83.92M |
| Operating Margin | -76.30% |
| Return on Equity | -891.00% |
| Return on Assets | -40.60% |
| Revenue/Share (TTM) | $10.55 |
| Book Value | $-11.78 |
| Price-to-Book | 12.05 |
| Price-to-Sales (TTM) | 1.43 |
| EV/Revenue | 2.351 |
| EV/EBITDA | -1.85 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.80% |
| Shares Outstanding | $22.66M |
| Float | $14.70M |
| % Insiders | 4.68% |
| % Institutions | 83.69% |
Historical Volatility
HV 10-Day
75.38%
HV 20-Day
91.65%
HV 30-Day
79.52%
HV 60-Day
93.05%
HV Rank
41.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($13.50 target)
2
Strong Buy4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026